Reply  by Shemesh, David et al.
LETTERS TO THE EDITORRegarding “Tips and tricks for avoiding access
problems when using large sheath endografts”
We read with interest the timely review by Peterson and
Matsumura.1 Hostile iliofemoral access is a leading constraint to
the general ability of achieving endovascular repair of thoracic and
aortic aneurysms. We would like to draw attention to another
strategy for overcoming this common clinical dilemma that was
not discussed by the authors: utilization of the common carotid
artery. Our institution2 is among other institutions that have
described use of the common carotid artery for thoracic aortic
aneurysm endovascular repair and coverage of penetrating thoracic
aorta ulcers.3-5 More recently, we have used this access route for
abdominal aortic aneurysm repair using a custom made, reverse-
mounted endograft.6
To accommodate a 28F thoracic endograft, the common
carotid artery should be 8 mm in luminal diameter and free of
disease. Accordingly, carotid ultrasound assessment is essential to
measure vessel diameter and atherosclerotic burden. This assess-
ment may be augmented by computed tomography imaging of the
intracranial and extracranial carotid system to visualize vessel cali-
ber and the anastomoses at the circle of Willis. Although carotid
shunting to preserve cerebral perfusion is not possible with this
approach, intraoperative transcranial Doppler measurement of the
middle cerebral artery provides an indication of the patient’s tol-
erance to carotid manipulation.
A further procedural modification to avoid brain hypoxia is
construction of a temporary extracorporeal axillocarotid graft to
maintain cerebral perfusion in the presence of coexisting carotid
disease or retrograde vertebral artery flow.7 A technical hazard to
note from this procedure is “cheese-wiring” of the guidewire
through the aortic wall at the angle of carotid intersection with the
aortic arch. This may been avoided by ensuring that a long sheath
is situated within aorta at all times.
We believe that in appropriately selected patients, the com-
mon carotid arteries provide a practical alternative route for endo-
vascular access for both thoracic and abdominal aortic endovascu-
lar interventions.
Jonathan Ghosh, MD, MA, FRCS
Ferdinand Serracino-Inglott, MD, MSc, FRCS
Manchester Royal Infirmary
Manchester, United Kingdom
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Regarding “Angioplasty with stent graft versus bare
stent for recurrent cephalic arch stenosis in
autogenous arteriovenous access for hemodialysis: A
prospective randomized clinical trial”
David Shemesh et al1 reported significantly better primary
patency rates for covered stents compared to bare stents in early
recurring stenoses of the final arch of the cephalic vein. Although
the authors acknowledge in the Discussion that these “stents can
cause occlusion of the axillary/subclavian vein” so “that the arm is
no longer available for (a new) arteriovenous access construction”,
we disagree when they say that this is a rare phenomenon. From
our previous experience with stents in this location, even stents not
clearly protruding into the axillary/subclavian vein can cause ste-
nosis or occlusion, which then precludes any further creation of a
new ipsilateral vascular access. There are, to date, no criteria to help
predict this severe complication. We have previously emphasized
the drawbacks of axillary-subclavian stents in a published letter.2
We believe that the conclusion of Dr Shemesh’s article pro-
moting placement of covered stents in cephalic arches should be
toned down, since such stent placements should be prohibited in
patients with a reasonably long life expectancy. The preservation of
venous capital in such patients is more important than any slight
prolongation of patency of the brachial-cephalic fistula, which
eventually requires redilation despite covered stent placement.
Unfortunately, it is difficult to predict the likely survival of the
majority of dialysis patients and, thus, the need for precaution
should lead to questioning the majority of potential indications for
stent placement in cephalic arches.
Luc A.E. Turmel-Rodrigues
Clinique Saint-Gatien
Department of Radiology
Tours, France
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Reply
We thank Dr Turmel-Rodrigues for his comment that high-
lights important issues concerning stent insertion for arteriovenous
access in general, extending beyond the specific area of the cephalic
arch discussed in our article.1
Dr Turmel-Rodrigues suggests that stent placement in the
cephalic arch should be avoided. To support this recommendation,
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vein is not a rare phenomenon. His published letter purporting to
emphasize all “the drawbacks of such stent placement” relates to
the placement of bare stents in central veins only.2 There is no
reference to the arch of the cephalic vein which was the subject of
our article. The previous letter published by Dr Turmel-Rodrigues
expresses his opinion but lacks data.2 However, it is an excellent
illustration in support of our contention that the use of bare stents
should be abandoned for venous stenoses related to arteriovenous
access.
Our experience is quoted in this prospective randomized
study: there were no axillary/subclavian occlusions in the 25
patients studied in short-term and long-term follow-up. The cases
Fig. Stent grafts do not appear to behave like prosthetic
the vein by the stent graft if the stent diameter is app
ultrasonography showing the peripheral (a) and central
segment stenosis seven months after deployment.of occlusion described included one other that occurred outside of
the study where the stent was clearly protruding into the axillary/
subclavian vein at the time of placement, but this patient did not
occlude. Only one of our patients occluded the subclavian vein
after deployment of a bare stent in the cephalic arch in the years
prior to the initiation of our study. This appears to us to amount to
a rare event. As a referral center, we have also seen a few other cases
of axillary/subclavian vein occlusion diagnosed in preoperative
venography for new access, even with minimal protrusion, after
stenting at other centers. We deliberately described these patients
and those with arches kinked by the stent in order to emphasize the
importance of the type of stent used, its length and accuracy in its
positioning in the cephalic arch, so that our experience of the
ovenous accesses since there is no disturbance of flow in
ate. This can be clearly visualized with color Doppler
ds of the stent with laminar flow and no evidence of inarteri
ropri
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shared with others. We are keenly aware of the need to preserve
“venous capital” but have not found stenting of the cephalic arch
to be a factor in its diminution. This is borne out by our life-table
analysis for a 1 year functional patency of 100%.1
Stent placement in the cephalic arch, as elsewhere, is an
attempt to preserve patency of an existing access. Our study
showed that covered stents demonstrated significantly better pa-
tency than bare stents.1 The rate of restenosis requiring dilatation
in the stent graft group was half of that in the bare stent group. This
was a significant improvement but, as Dr Turmel-Rodrigues states,
redilatations are still required despite covered stent placement. In
fact, in the constellation of conserving venous capital, dilatations
and redilatations are required to keep accesses open and to increase
dialysis time for any particular access, stented or not.3
Our study clearly showed that the use of bare stents for
cephalic arch restenosis does not prevent rapid in-stent restenosis.
Stent grafts performed significantly better and are the preferred
solution for this lesion with improved patency and decrease in
re-intervention rates (Fig). It is logical to extrapolate from this
study that bare stents are not an appropriate solution for any
venous lesion in arteriovenous accesses that require stents and that
covered stents will do better. Moreover, we would encourage the
use of stent grafts that are completely covered and flexible. Need-
less to say, we think it incorrect to apply reported anecdotal
findings concerning bare stent occlusions in central veins to the
deployment of stent grafts in cephalic arch restenosis. We do not
see any reason to prohibit their use in this circumstance.
David Shemesh, MD, RVT
Ilya Goldin, MD
Oded Olsha, MB, BS
Shaare Zedek Medical Center
Jerusalem, Israel
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Regarding “Impact of calcification and intraluminal
thrombus on the computed wall stresses of abdominal
aortic aneurysm”
We read with great interest the article by Li et al, concerning
the effect of intraluminal thrombus on the values of peak wall
stress, in 3D reconstructed individualized abdominal aortic aneu-
rysm (AAA) models.1 After having used the method of Finite
Element Analysis, the authors concluded that the relative amount
on thrombus reduces the maximum stress in AAA in a rather linear
way (r  0.863, P  .001). This is one of the largest series (20
patients) with a rather interesting finding, adding to the existing
information about the biomechanical influence of thrombus on
maximum stress and consequently on the risk of rupture.2
Although the amount of thrombus is sufficiently addressed,
we believe that an additional point needs to be considered, namely
the concurrent influence of the geometric modifications inside the
lumen that the existence of thrombus induces, when compared
with reconstructed AAA models without thrombus. These shiftscan be represented by the alterations in the mean curvature,
torsion, tortuosity in the lumen centerlines in each case.3
In our laboratory, we also used the Finite Element Analysis
method and confirmed the good level of correlation between the
reduction in maximum stress and the relative amount of thrombus
in a series of 19 patients (Spearman’s non parametric r  0.5, P 
.03). However, when we used a partial correlation analysis (non
parametric Spearman test), enabling us to control for the difference
in the geometry parameters that have shown to have an influence
on maximum stress magnitude,4 we failed to show any statistical
significance for the relationship between stress reduction and the
relative amount of thrombus (Spearman’s   0.413, P  .112).
This may imply that the protective role of thrombus is not only a
matter of amount, but could be influenced by the geometry of its
distribution. This observation could offer a new insight into the
limitations of the protective role of thrombus.
Efstratios Georgakarakos, MD
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We thank Dr Georgakarakos et al for the interest they have
shown in our study.1 They confirmed our finding in their study
that a good correlation existed between maximum wall stress and
the relative amount of thrombus. However, by employing partial
correlation analysis and controlling the geometric variations, they
reported that the difference between the above was not statistically
significant. This might imply that peak wall stress was affected by
the geometric variations rather than the amount of thrombus
alone.
We would like to impress on the point that although this may
be the case, the geometric variation is itself dependent on the
volume and location of the thrombus. The concentricity or eccen-
tricity of thrombus by changing the centerline curvature can alter
the peak wall stress. The location and volume of thrombus may also
affect the pattern of aneurysm expansion.2,3 There is an analogy
between the role of thrombus in altering the aneurysm wall stress
and the role of calcification in atheromatous plaques. Convention-
ally, the amount of calcification was used as an indicator of plaque
vulnerability but our group has shown that location is another key
determinant of plaque vulnerability.4 Similarly, we hypothesize
